1.
N Engl J Med
; 343(10): 740-1, 2000 Sep 07.
Article
in English
| MEDLINE
| ID: mdl-10979776
Subject(s)
Antineoplastic Agents/adverse effects , Corneal Diseases/chemically induced , Deoxycytidine/analogs & derivatives , Deoxycytidine/adverse effects , Visual Acuity/drug effects , Breast Neoplasms/secondary , Capecitabine , Female , Fluorouracil/analogs & derivatives , Humans , Keratitis/chemically induced , Keratoconjunctivitis Sicca/complications , Middle Aged
2.
Am J Ophthalmol
; 126(6): 835-6, 1998 Dec.
Article
in English
| MEDLINE
| ID: mdl-9860013
ABSTRACT
PURPOSE: To determine if common ocular adenovirus serotypes survive in vitro in multidose bottles of topical fluorescein (Fluress; Pilkington Barnes Hind, Inc, Sunnyvale, California). METHODS: Clinical isolates of adenovirus types 8 and 19 were inoculated separately into 10 bottles each of Fluress and maintained at room temperature (25 C). All bottles were titered for adenovirus on A549 cell monolayers at 0, 7, 14, 21, 28, and 49 days. RESULTS: Adenovirus was recovered from Fluress for up to 21 days for adenovirus type 19 and 28 days for adenovirus type 8. CONCLUSION: A multidose bottle of Fluress contaminated with adenovirus can be a potential source of adenoviral transmission in an ophthalmic office setting.
